Showing results (1-10 of 243) with videos related to
Sort By:
Pageof 25
Clinical Neuropharmacology|April 6, 2001
Catechol-O-methyltransferase decreases levodopa toxicity in vitroD Offen, H Panet, R Galili-Mosberg, et al.Journal of Neurochemistry|April 12, 2001
Activation of nuclear transcription factor kappa B (NF-kappaB) is essential for dopamine-induced apoptosis in PC12 cellsH Panet, A Barzilai, D Daily, et al.Neuroscience Letters|December 20, 2005
Increased survival and migration of engrafted mesenchymal bone marrow stem cells in 6-hydroxydopamine-lesioned rodentsM A Hellmann, H Panet, Y Barhum, et al.Journal of Neural Transmission. Supplementum|June 17, 1999
Current management of motor fluctuations in patients with advanced Parkinson's disease treated chronically with levodopaE Melamed, J Zoldan, R Galili-Mosberg, et al.Cellular and Molecular Neurobiology|June 1, 1997
Dopamine-induced apoptosis is inhibited in PC12 cells expressing Bcl-2D Offen, I Ziv, H Panet, et al.Journal of Neural Transmission. Supplementum|November 7, 2007
Intrastriatal transplantation of mouse bone marrow-derived stem cells improves motor behavior in a mouse model of Parkinson's diseaseD Offen, Y Barhum, Y S Levy, et al.Apoptosis : an International Journal on Programmed Cell Death|January 1, 1997
The proto-oncogene Bcl-2 inhibits cellular toxicity of dopamine: possible implications for Parkinson's diseaseI Ziv, D Offen, R Haviv, et al.Current Drug Targets|February 22, 2005
Integral therapeutic potential of bone marrow mesenchymal stem cellsI Kan, E Melamed, D OffenCellular and Molecular Neurobiology|June 5, 2002
6-Hydroxydopamine increases ubiquitin-conjugates and protein degradation: implications for the pathogenesis of Parkinson's diseaseH Elkon, E Melamed, D OffenJournal of Neural Transmission. Supplementum|December 29, 2000
Apoptosis as a general cell death pathway in neurodegenerative diseasesD Offen, H Elkon, E MelamedPageof 25